Respiratory Devices Market to Reach USD 49.90 Billion by 2033 | CAGR 8.8% | North America Leads with 38% Share | Key Players: Fisher & Paykel Healthcare, ResMed, Philips, Medtronic, GE HealthCare, Invacare, CorVent, AstraZeneca

Respiratory Devices Market Size & Industry Outlook

The global respiratory devices market reached US$ 23.45 billion in 2024 and is projected to grow to US$ 49.90 billion by 2033, registering a CAGR of 8.8% during the forecast period (2025-2033). Respiratory devices are critical instruments designed to support normal lung function or protect users from airborne hazards by removing carbon dioxide and supplying oxygen. They play a vital role in the treatment and management of various respiratory disorders, ensuring proper ventilation and oxygenation for patients.

The market is witnessing robust growth driven by the rising prevalence of chronic respiratory diseases, increasing geriatric population, growing demand for home-based healthcare solutions, and continuous technological advancements. The shift toward portable, efficient, and patient-friendly respiratory care equipment is further propelling demand across hospitals, clinics, and homecare settings. Additionally, increasing awareness of respiratory health and the adoption of digital monitoring technologies are expanding the market's potential.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/respiratory-devices-market?Juli

Recent Developments:

✅ August 2024: The FDA approved the next-generation Inspire V therapy system, an upper airway stimulation device for moderate to severe obstructive sleep apnea (OSA) patients who cannot tolerate PAP treatments, broadening therapeutic options beyond conventional CPAP machines.

✅ May 2025: Leading respiratory care companies such as Philips, ResMed, Medtronic, and GE HealthCare introduced technologically advanced ventilators, portable non-invasive respiratory devices, and smart inhalers designed to improve patient comfort and treatment efficiency across hospital and homecare settings.

✅ April 2025: The market saw rapid adoption of AI-embedded and digitally connected respiratory monitoring systems, integrating cloud connectivity, remote monitoring, and predictive analytics to enhance patient management and telehealth-based respiratory care.

✅ February 2025: The demand for portable oxygen concentrators and multifunctional respiratory support systems surged, driven by the aging population, preference for home-based care, and rising cases of chronic respiratory disorders.

✅ January 2025: The sleep apnea device segment experienced major innovation, with companies such as ResMed expanding their digital health ecosystem through new acquisitions and the launch of next-generation diagnostic and homecare solutions.

Mergers & Acquisitions:

✅ November 2025: A leading global respiratory device manufacturer acquired an AI-driven pulmonary monitoring startup to strengthen its portfolio of connected care solutions and enhance remote patient management capabilities.

✅ September 2025: A major European medical technology firm partnered with a digital health analytics company, enabling co-development of predictive respiratory health platforms and enhanced device-to-cloud integration.

✅ July 2025: A top U.S. respiratory device company acquired a portable oxygen therapy specialist, expanding its footprint in home healthcare and broadening its range of lightweight, patient-centric oxygen delivery systems.

✅ May 2025: A multinational healthcare technology corporation completed the acquisition of a smart ventilator technology provider to accelerate product innovation and strengthen its position in intensive care and chronic respiratory support.

✅ March 2025: A prominent sleep therapy solutions company acquired a tele-health platform provider to integrate remote diagnostics and patient engagement features across its obstructive sleep apnea (OSA) device portfolio.

Key Players:
Fisher & Paykel Healthcare Limited | ResMed | Koninklijke Philips N.V. | Medtronic | GE HealthCare | Drägerwerk AG & Co. KGaA | Getinge AB | Masimo Corporation | Baxter International Inc. | Invacare Corporation | CorVent Medical | AstraZeneca

Key Highlights:

• Fisher & Paykel Healthcare Limited - Holds a leading market share driven by its advanced humidification systems, respiratory support devices, and high-flow oxygen therapy solutions used across intensive care and homecare settings.

• ResMed - Commands a strong presence in the sleep apnea and non-invasive ventilation segments, supported by digital health integration and cloud-connected devices for remote patient monitoring.

• Koninklijke Philips N.V. - Focused on innovative ventilators, oxygen concentrators, and portable respiratory care systems, complemented by its robust telehealth and AI-based analytics platforms.

• Medtronic - Holds a significant share in invasive and non-invasive ventilation systems, leveraging strong R&D and global distribution networks for hospital and emergency care devices.

• GE HealthCare - Specializes in advanced respiratory monitoring, ventilator technology, and diagnostic imaging integration for comprehensive respiratory care solutions.

• Drägerwerk AG & Co. KGaA - Known for its high-quality critical care ventilators and patient monitoring systems, widely used in hospital intensive care units worldwide.

• Getinge AB - Offers a broad range of mechanical ventilators and respiratory care technologies focused on clinical efficiency and patient safety.

• Masimo Corporation - Excels in respiratory monitoring technologies, including pulse oximetry and capnography systems, enhancing real-time patient assessment.

• Baxter International Inc. - Expanding its presence through acquisition-driven innovation in respiratory therapy and patient monitoring solutions.

• Invacare Corporation - A key player in home respiratory care, providing oxygen concentrators, nebulizers, and mobility-integrated breathing support devices.

• CorVent Medical - Focused on developing portable, scalable, and cost-effective ventilator systems designed for emergency and intensive care use.

• AstraZeneca - Strengthening its position through respiratory drug-device combinations and smart inhaler technologies, integrating pharmacological and device-based therapy.

Buy Now & Unlock 360° Market Intelligence:-https://www.datamintelligence.com/buy-now-page?report=respiratory-devices-market?Juli

Market Segmentation:

➥ By Product Type, Therapeutic Devices dominate the market with a 40% share, driven by high demand for ventilators, oxygen concentrators, and CPAP/BiPAP systems used in both hospital and homecare settings. Monitoring Devices hold a 25% share, supported by the rising adoption of respiratory monitoring systems, pulse oximeters, and capnography devices for continuous patient tracking. Diagnostic Devices account for 15%, including spirometers, peak flow meters, and gas analyzers used for respiratory disease assessment. Consumables & Accessories represent 15%, encompassing masks, circuits, filters, and tubing essential for device operation. Others contribute 5%, including novel respiratory interfaces and AI-based monitoring tools.

➥ By Application/Indication, Chronic Obstructive Pulmonary Disease (COPD) leads with a 30% share, owing to the growing global burden of COPD and increased adoption of maintenance and home ventilation therapies. Asthma holds a 25% share, supported by rising prevalence and advancements in smart inhalers and nebulizers. Sleep Apnea accounts for 20%, driven by increasing diagnosis rates and adoption of PAP therapy devices. Pneumonia contributes 10%, with demand for ventilatory and oxygen support devices during acute respiratory episodes. Cystic Fibrosis holds 8%, and Bronchitis and Others represent 7%, collectively fueled by hospital and outpatient management of chronic respiratory infections.

➥ By Portability, Stationary Devices account for a 55% share, widely used in hospitals and intensive care units for long-term ventilation and respiratory monitoring. Portable Devices hold a 45% share, gaining momentum with the rise of home healthcare, telemonitoring, and patient preference for mobility and comfort.

➥ By End-User, Hospitals dominate with a 40% share, driven by the increasing use of respiratory support systems in critical care and emergency settings. Homecare Settings follow with a 30% share, reflecting the growing trend toward home-based management of chronic respiratory diseases. Ambulatory Surgical Centers (ASCs) represent 10%, utilizing respiratory monitoring and post-anesthesia recovery devices. Clinics hold a 10% share, providing outpatient diagnostic and therapeutic respiratory care, while Emergency Medical Services (EMS)/Transport account for 10%, supported by the demand for portable and rapid-response ventilation systems.

Speak to Our Analyst and Get Customization in the report as per your requirements:-https://www.datamintelligence.com/customize/respiratory-devices-market?Juli

Market Dynamics:

Drivers:
The rising prevalence of respiratory diseases is one of the most significant drivers of growth in the global respiratory devices market, as it directly increases the demand for therapeutic, diagnostic, and monitoring devices. Conditions such as chronic obstructive pulmonary disease (COPD), asthma, bronchitis, and pneumonia are becoming more common due to factors such as smoking, air pollution, allergens, viral and bacterial infections, and environmental changes. According to the World Health Organization (WHO), over 80 million people globally are affected by respiratory diseases, with many more cases remaining undiagnosed.

Furthermore, around 81.7 million people are currently living with chronic respiratory diseases (CRDs), and 6.8 million new cases are diagnosed annually. Despite the growing burden, CRDs have often been deprioritized in public health agendas, leaving millions without adequate access to care. COPD and asthma account for the majority of CRD cases worldwide. Projections indicate that COPD prevalence will increase by approximately 23% globally between 2020 and 2050, with the steepest rise expected among women and in low- and middle-income countries. Hospitalization rates for asthma also remain high, particularly among children and young adults, despite the availability of effective therapies. These trends underscore the urgent need for advanced respiratory devices for both hospital and homecare use, fueling sustained market growth.

Restraints:
The high cost of advanced respiratory devices remains a major restraint on market growth. These devices are life-sustaining medical technologies that require precision engineering, strict regulatory compliance, premium materials, and continuous post-sale maintenance factors that collectively increase production and procurement costs. Additionally, respiratory devices are manufactured in smaller quantities compared to consumer electronics, further raising unit prices.

For healthcare providers, acquiring ventilators and other respiratory support systems represents a substantial capital investment. The cost of mechanical ventilators can range from USD 5,000 to USD 50,000, depending on the model and intended use. High-acuity or premium ventilators commonly used in intensive care units (ICUs) typically cost between USD 25,000 and USD 50,000 and are equipped with advanced gas delivery systems, sensors, and digital monitoring capabilities. Such high costs can limit adoption, particularly in resource-constrained settings and developing markets, thereby restraining overall market growth despite increasing clinical demand.

Regional Insights:

North America dominates the respiratory devices market, accounting for approximately 38% of the global share in 2024. The region's leadership is attributed to a high prevalence of chronic respiratory diseases such as COPD and sleep apnea, advanced healthcare infrastructure, and strong adoption of home-based respiratory care. The United States is the largest contributor within the region, supported by favorable reimbursement policies, extensive R&D activities, and the presence of major players like ResMed, Philips, and GE HealthCare. Continuous innovation in portable oxygen concentrators, digital monitoring devices, and non-invasive ventilators further strengthens the region's market position.

Europe holds the second-largest share, representing around 27% of the global market. Rising air pollution levels, a growing geriatric population, and increasing adoption of advanced ventilatory support systems are driving growth across key markets such as Germany, the UK, France, and Italy. The region's stringent regulatory standards, along with public health programs promoting respiratory wellness and pollution control, contribute to steady demand for diagnostic and therapeutic devices.

The Asia-Pacific (APAC) region is expected to witness the fastest growth during the forecast period, currently holding about 22% of the global share. Rapid urbanization, high smoking rates, deteriorating air quality, and increasing healthcare expenditure are fueling the need for respiratory support and monitoring systems in countries such as China, India, and Japan. Growing awareness about sleep disorders, coupled with an expanding homecare segment, is further propelling market expansion in APAC.

Latin America accounts for approximately 8% of the global share, driven by the rising incidence of respiratory infections, improving healthcare access, and growing adoption of affordable ventilators and oxygen therapy equipment in countries like Brazil and Mexico.

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape

✅ Sustainability Impact Analysis

✅ KOL / Stakeholder Insights

✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots

✅ Market Volatility & Emerging Risks Analysis

✅ Quarterly Industry Report Updated

✅ Live Market & Pricing Trends

✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?Juli

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.